Fatty Acid Oxidation (β-Oxidation)
USMLE Step 1 trap: Reverses malonyl-CoA's inhibitory role — it inhibits beta-oxidation (via CPT-I), not synthesis. Malonyl-CoA (the first committed intermediate of FA synthesis) inhibits carnitine acyltransferase I, blocking entry of fatty acids into mitochondria for beta-oxidation.
Beta-oxidation is the stepwise degradation of fatty acids in the mitochondrial matrix, producing acetyl-CoA, NADH, and FADH2 that feed directly into the TCA cycle and oxidative phosphorylation. USMLE Step 1 tests this topic from multiple angles: the carnitine shuttle mechanism and its regulation, per-cycle yield calculations, a classic pediatric metabolic disease (MCAD deficiency), and ketogenesis as a downstream consequence. Students consistently confuse the direction of malonyl-CoA's action — it inhibits beta-oxidation, not synthesis — and miss that MCAD deficiency causes hypoketotic hypoglycemia precisely because ketone production is impaired, not increased. Expect both direct recall questions and clinical vignettes where you have to work backwards from a lab picture to the enzyme defect.
From real student decks
86%have cards covering this topic
65%have mature cards
Common misconceptions
Common mistake
Wrong: Malonyl-CoA inhibits fatty acid synthesis rather than fatty acid oxidation.
Right: Malonyl-CoA (the first committed intermediate of FA synthesis) inhibits carnitine acyltransferase I, blocking entry of fatty acids into mitochondria for beta-oxidation.
Malonyl-CoA is the first committed intermediate of fatty acid synthesis, made by acetyl-CoA carboxylase. Its job is to signal 'we are already building fat — don't burn it simultaneously.' It does this by inhibiting CPT-I, which blocks the carnitine shuttle and prevents long-chain fatty acids from entering the mitochondria for oxidation. So malonyl-CoA inhibits beta-oxidation (the burning pathway), not synthesis — it IS part of the synthesis pathway.
Common mistake
Wrong: The liver can use ketone bodies it produces as an energy source.
Right: The liver lacks succinyl-CoA transferase (thiophorase) and therefore cannot utilize ketone bodies, which are exported for use by brain, heart, and muscle.
The liver makes ketone bodies precisely because it has robust ketogenic enzymes, but it ships them out rather than using them locally. The reason is the absence of succinyl-CoA transferase (also called thiophorase), the enzyme that reactivates acetoacetate back to acetoacetyl-CoA for further oxidation. Without it, the liver's own ketones are metabolically inert to the liver itself. Brain, cardiac muscle, and skeletal muscle all have this enzyme and can consume ketones avidly.
Common mistake
Wrong: MCAD deficiency primarily causes ketoacidosis because fat oxidation is impaired.
Right: MCAD deficiency causes hypoketotic hypoglycemia because impaired beta-oxidation reduces acetyl-CoA for ketogenesis, leaving the patient without both glucose and ketone energy sources during fasting.
In MCAD deficiency, medium-chain fatty acids cannot be oxidized, so acetyl-CoA production is impaired. Less acetyl-CoA means less substrate for ketogenesis — so ketone levels are paradoxically low, not high. Meanwhile, glucose is consumed faster because fatty acid backup energy is unavailable, causing hypoglycemia. The combination of low glucose AND low ketones (hypoketotic hypoglycemia) is the hallmark. Ketoacidosis would imply excess ketone production, which is the opposite of what happens here.
Common mistake
Gap: Misses that odd-chain FA oxidation produces propionyl-CoA requiring B12 and biotin for further metabolism
Odd-chain fatty acid oxidation yields propionyl-CoA in the final cycle, which requires vitamin B12 and biotin to be converted to succinyl-CoA for entry into the TCA cycle.
Even-chain fatty acids cleanly produce acetyl-CoA all the way through. Odd-chain fatty acids are different: the final cycle leaves a 3-carbon propionyl-CoA instead of a 2-carbon acetyl-CoA. Propionyl-CoA must be carboxylated to methylmalonyl-CoA (requires biotin) and then rearranged to succinyl-CoA (requires vitamin B12/adenosylcobalamin) for TCA entry. This is why B12 deficiency and methylmalonic acidemia appear on Step 1 in the context of fat metabolism, not just neurological disease.
What the exam tests
- Understand the carnitine shuttle: long-chain fatty acids must be converted to acylcarnitine by CPT-I (carnitine acyltransferase I) on the outer mitochondrial membrane to cross into the matrix, and malonyl-CoA inhibits CPT-I to prevent futile cycling during active fatty acid synthesis.
- Calculate the ATP yield per cycle of beta-oxidation and for a full-length fatty acid like palmitate (16 carbons, 7 cycles, yielding 8 acetyl-CoA plus 7 NADH and 7 FADH2).
- Recognize MCAD deficiency by its presentation: hypoketotic hypoglycemia triggered by fasting in a young child, with dicarboxylic aciduria and elevated medium-chain acylcarnitines on newborn screen — and understand why ketones are absent rather than elevated.
- Explain the trigger and products of ketogenesis (occurs in liver mitochondria when acetyl-CoA exceeds TCA cycle capacity), the two major ketone bodies (acetoacetate and beta-hydroxybutyrate), and why the liver itself cannot use the ketones it makes due to absence of succinyl-CoA transferase.
- Know that odd-chain fatty acid oxidation terminates in propionyl-CoA, which requires biotin (propionyl-CoA carboxylase) and vitamin B12 (methylmalonyl-CoA mutase) for conversion to succinyl-CoA and entry into the TCA cycle.
Can you avoid these mistakes?
A patient is started on a high-carbohydrate meal after fasting. Malonyl-CoA levels rise. What happens to CPT-I activity and why does this make physiological sense?
Palmitic acid is a 16-carbon saturated fatty acid. How many cycles of beta-oxidation does it undergo, and what is the total yield of acetyl-CoA, NADH, and FADH2 before accounting for TCA cycle entry?
A 6-month-old presents with hypoglycemia and lethargy after a 12-hour fast. Labs show low glucose, low ketones, and elevated C8-acylcarnitine on newborn screen. What enzyme is deficient, and why are ketones low rather than high?
Why can the brain use ketone bodies during prolonged starvation but the liver — which produces them — cannot? Name the specific enzyme the liver lacks.
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →